Table 1.
Clinical Data from HCC and CCA Patients Enrolled in This Study
| CCA (n = 8) |
HCC (n = 21) |
||
|---|---|---|---|
| Age | 61 ± 15 | 62 ± 15 | |
| Sex | Female | 5 (63%) | 3 (14%) |
| Male | 3 (38%) | 18 (86%) | |
| TNM | Stage I | 1 (13%) | 3 (14%) |
| Stage II | 4 (50%) | 16 (76%) | |
| Stage IIIA | 0 (0%) | 1 (5%) | |
| Stage IV | 3 (38%) | 1 (5%) | |
| Histologic grade (G) | G1 | 2 (25%) | 2 (9%) |
| G2 | 3 (38%) | 12 (57%) | |
| G3 | 3 (38%) | 6 (29%) | |
| G4 | 0 (0%) | 1 (5%) | |
| Risk stratification | Low | 2 (25%) | 10 (48%) |
| High | 6 (75%) | 11 (52%) | |
| HBsAg | Positive | 0 (0%) | 1 (5%) |
| HCV | Positive | 0 (0%) | 6 (29%) |
| Cirrhosis | 0 (0%) | 16 (76%) | |
| Relapse | 3 (38%) | 1 (5%) | |
| Death | 3 (38%) | 2 (9%) | |
| Liver transplant | 0 (0%) | 7 (33%) | |
Number (N) and percentage (%) of cases are indicated.